Cost and Quality

Latest KFF Health News Stories

KHN’s ‘What the Health?’: Dealing With Drug Prices

KFF Health News Original

Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.

App Attempts to Break Barriers to Bankruptcy for Those in Medical Debt

KFF Health News Original

Medical bills are a leading reason people get stuck in a cycle of debt. Declaring bankruptcy is one lifeline, but attorney and court fees can put it out of reach. The nonprofit Upsolve created an app it calls the “TurboTax of bankruptcy” to help people hit the reset button and rebuild their financial lives.

Clinics Say State’s New Medicaid Drug Program Will Force Them to Cut Services

KFF Health News Original

On Jan. 1, California started buying prescription drugs for its nearly 14 million Medicaid enrollees, a responsibility that had primarily been held by managed-care insurance plans. State officials estimate California will save hundreds of millions of dollars by flexing its purchasing power, but some health clinics expect to lose money.

California Ballot Will Be Heavy on Health Care

KFF Health News Original

In the Nov. 8 general election, California voters will consider overturning the state’s flavored tobacco ban and hiking medical malpractice awards. Other proposals to decriminalize psychedelic mushrooms, target dialysis clinics and boost public health funding could also be on the ballot, along with a plan to limit business and school closures during public health emergencies.

KHN’s ‘What the Health?’: Manchin Blows Up Biden’s ‘Build Back Better’

KFF Health News Original

Sen. Joe Manchin (D-W.Va.) dealt a blow to congressional efforts to pass President Joe Biden’s domestic agenda bill, forcing Democrats to regroup starting in 2022. Meanwhile, the omicron covid variant spreads rapidly in the U.S., threatening the stability of the nation’s health care system. Joanne Kenen of Politico and the Johns Hopkins School of Public Health, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more, plus a look back at the year in health policy. Also this week, Rovner interviews Ceci Connolly, president and CEO of the Alliance of Community Health Plans.